Vaccine-maker Biological E (BE), has received World Health Organization’s (WHO) pre-qualification (PQ) status for its 14-valent pneumococcal conjugate vaccine (PCV), Pneubevax 14. Developed ...
The company has developed the vaccine with Baylor College of Medicine in Houston and Dynavax Technologies Corp. Late last month it received approval from India's drug regulator to conduct a Phase III ...
Hosted on MSN
South Africa's Biovac, India's Biological E ink vaccine tech transfer deal to boost Africa supply
Biovac, a biopharmaceutical company in South Africa, and Biological E, a Supplier of vaccines globally from India, have signed a groundbreaking technology transfer agreement to manufacture and ...
InDevR, Inc., a leader in analytical solutions for vaccine in-process and quality control testing, and Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ...
Jiangsu Recbio Technology Company Limited (02179.HK), announced that they have entered into a licensing cooperation agreement, and have commenced the technology transfer of their Recombinant 9-valent ...
Biopharmaceutical company Dynavax Technologies Corporation (NASDAQ:DVAX) recently revealed that Biological E, an Indian biotechnology and biopharmaceutical company, has received emergency use ...
Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...
Trivalent egg-based A/Thailand/8/2022 (H3N2) A/Croatia/10136RV/2023 (H3N2) H3N2 strain substituted Trivalent cell/recombinant A/Massachusetts/18/2022 (H3N2) A/District of Columbia/27/2023 (H3N2) H3N2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback